MARILAO MEDICAL & DIAGNOSTIC CLINIC, INC.

Processed by:
(JONI VILLANUEVA MOLECULAR DIAGNOSTIC LABORATORY)
IGULOT RD., BRGY. IGULOT, BOCAUE, BULACAN.
Department of Health License No.: 03-0062-2022-CT-2
Contact No. 09266281654

STMA-0003475
Name: VENANCIO, JOAN SILVESTRE
Age: 31
Sex: Female
Date of birth (YYYY-MM-DD): 1991-05-22
Address: 192 CENTRO SANTA CRUZ SANTA MARIA BULACAN REGION III

Passport #: 0
Hospital/LGU: LGU STA MARIA
Specimen type: Nasopharyngeal / Oropharyngeal swab
Lab ID: 0205297
Specimen ID: STMA-0003475
Mobile No.: 09232401276
Nationality: FILIPINO
Date & time of collection (YYYY-MM-DD/HH:MM:SS): 2022-07-01 09:16:00
Date & Time of receipt in the lab (YYYY-MM-DD/HH:MM:SS): 2022-07-01 19:46:59
Date & Time release of results (YYYY-MM-DD/HH:MM:SS): 2022-07-01 23:49:28

PATHOLOGY TEST PERFORMED

Molecular Diagnostic Test

SARS – CoV-2 (causative agent of Covid-19) viral RNA detection by Real-Time Reverse Transcription Polymerase Chain Reaction

RESULT: 2022-07-01 23:49:28

SARS-CoV-2 (causative agent of COVID-19) viral RNA NOT DETECTED

INTERPRETATION:

NEGATIVE
....
METHOD: Real-Time Reverse Transcription Polymerase Chain Reaction (qRT-PCR) was performed to test the presence of SARS-CoV-2 viral RNA. RNA
extraction was performed using an automated RNA extraction machine to purify viral RNA in the sample. FDA approved SARS-CoV-2 qRT-PCR reagent kits
were used to detect SARS-CoV-2 specific gene targets (RdRp/N/ORF1ab/NSP-3). Amplification and detection were done using BIORAD CFX96 Real-Time
PCR machine with positive and negative controls included in each run to confirm validity and accuracy of results.
TEST: Qualitative detection of SARS-CoV-2, the causative agent of COVID-19, extracted from nasopharyngeal & oropharyngeal swab samples.
LIMITATION: Pre-analytical variables such as sample collection, storage, handling and transport may affect the quality of results. The detection of viral RNA is
dependent on the viral load if the sample was collected early and/or late in the course of infection. PCR results should not be used as the sole basis of patient
treatment management decision. PCR results should be interpreted by a physician in conjunction with review of patient’s history and clinical signs and
symptoms.
QUALITY ASSURANCE: MMDC is comprised of trained laboratory personnel in performing molecular diagnostic assays and passed the external proficiency
testing conducted by the Department of Health – Research Institute for Tropical Medicine.

VENANCIO

Powered by TCPDF (www.tcpdf.org)